Pharma / Biotech

FDA Approves Adakveo for Painful Complication of Sickle Cell Disease

The FDA approved crizanlizumab-tmca for sickle cell patients 16 and older who suffer vaso-occlusive crisis, a common and painful complication of sickle cell diseas.

Source link

Related posts

Steroids Linked to Post-op Complications in UC Patients


Pharmacokinetics and pharmacodynamics of a single dose of sustained-release azithromycin formulation in pigeons.


LICE (Piperonyl Butoxide, Pyrethrum Extract) Shampoo [Rite Aid Corporation]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy